You are here

Kisqali

Novartis heaps pressure on Lilly with broad FDA approval for Kisqali in early breast cancer

Fierce Pharma

Tue, 09/17/24 - 11:08 pm

Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction

Clinical Trials Arena

Mon, 09/16/24 - 10:56 am

clinical trials

Novartis pauses enrollment in some Kisqali trials to fix manufacturing

BioPharma Dive

Wed, 04/10/24 - 05:28 pm

drug manufacturing

clinical trials

Novartis gears up for label expansion for Kisqali with Phase III results

Clinical Trials Arena

Mon, 12/11/23 - 11:18 am

clinical trials

early breast cancer

ASCO in Review: Oncologists See Practice-Changing, Affirming Data

BioSpace

Thu, 06/8/23 - 09:26 pm

non-small cell lung cancer

Moderna Therapeutics

Novartis drug helps stop breast cancer’s return in large study

BioPharma Dive

Fri, 06/2/23 - 11:24 am

clinical trials

ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers

Fierce Pharma

Thu, 05/25/23 - 08:33 pm

non-small cell lung cancer

early breast cancer

Novartis' Kisqali cuts recurrence risk in early-stage breast cancer

BioSpace

Mon, 03/27/23 - 11:27 am

clinical trials

Novartis’ Kisqali Hits Mark in Mid-Stage Breast Cancer Trial

BioSpace

Wed, 12/7/22 - 11:39 pm

clinical trials

Novartis presents new Kisqali data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer

Drugs.com

Sun, 09/19/21 - 11:58 pm

clinical trials

#ASCO21: Novartis keeps building out survival data for Kisqali, hoping to keep the pressure on Pfizer's Ibrance

Endpoints

Thu, 06/3/21 - 12:09 am

SABCS: Novartis touts Kisqali's 5-year breast cancer survival, advantage over Pfizer's Ibrance

Fierce Pharma

Wed, 12/9/20 - 10:51 am

Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation

RAPS.org

Sun, 09/15/19 - 09:47 pm

Novartis' Kisqali sharpens survival edge with second ph3 win

Fierce Pharma

Thu, 08/1/19 - 12:00 am

clinical trials

ASCO: Novartis' Kisqali posts first-in-class survival win in younger women

Fierce Pharma

Sat, 06/1/19 - 12:45 pm

clinical trials

NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartisspir

Fierce Pharma

Sat, 10/20/18 - 10:37 pm

FDA Approves First Cancer Drug Under New Real Time Review Program

CP Wire

Wed, 07/18/18 - 01:39 pm

Real Time Oncology Review

FDA Approves First Cancer Drug Under New Real Time Review Program

Wed, 07/18/18 - 01:38 pm

ASCO: Novartis makes a case for earlier Kisqali use. Will 'conservative' docs run with it?

Fierce Pharma

Mon, 06/4/18 - 09:31 am

metastatic breast cancer

HER2-negative breast cancer

Cancer Space Update: New Regulatory Status for 3 Major Drugs

Yahoo/Zacks.com

Fri, 01/5/18 - 05:33 pm

Seattle Genetics

Pages